MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Corcept Therapeutics Incorporated Depreciation & Amortization 2011-2026 | CORT
Annual Depreciation & Amortization Corcept Therapeutics Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 795 K | 1.04 M | 1.26 M | 1.07 M | 525 K | 703 K | 236 K | 106 K | 87 K | 155 K | 141 K | 74 K | 27 K | 3 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.26 M | 3 K | 445 K |
Quarterly Depreciation & Amortization Corcept Therapeutics Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 285 K | - | - | 120 K | - | - | 172 K | - | 599 K | - | 288 K | - | 783 K | - | 254 K | - | 447 K | 362 K | 238 K | - | 474 K | 263 K | 96 K | - | 163 K | 105 K | 48 K | - | 58 K | 22 K | 13 K | - | 72 K | 51 K | 27 K | - | 127 K | 97 K | 40 K | - | 104 K | 65 K | 28 K | - | 53 K | 33 K | 14 K | - | 14 K | 8 K | 3 K | - | 1 K | 1 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 783 K | 1 K | 154 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M |  USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
19.3 M | $ 18.38 | -0.68 % | $ 2.7 B | USA |
 |
Amgen
AMGN
|
5.59 B | $ 344.65 | 0.81 % | $ 185 B | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
22.2 M | $ 71.99 | 3.84 % | $ 9.63 B | USA |
 |
Biogen
BIIB
|
673 M | $ 178.18 | -0.95 % | $ 25.9 B | USA |
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M |  China |
 |
Aytu BioScience
AYTU
|
5.38 M | $ 2.65 | 1.92 % | $ 16.6 M | USA |
 |
Adagene
ADAG
|
723 K | $ 2.96 | 7.64 % | $ 167 M | China |
 |
Can-Fite BioPharma Ltd.
CANF
|
14 K | $ 4.16 | 3.74 % | $ 9.05 B |  Israel |
 |
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | USA |
 |
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | USA |
 |
Compugen Ltd.
CGEN
|
461 K | $ 1.86 | 1.1 % | $ 167 M | Israel |
 |
Aptose Biosciences
APTO
|
32 K | - | -45.71 % | $ 1.2 M |  Canada |
 |
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M | Canada |
 |
Celldex Therapeutics
CLDX
|
3.18 M | $ 24.86 | 1.06 % | $ 1.6 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
1.58 M | $ 1.41 | - | $ 264 M | USA |
 |
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
363 K | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | USA |
 |
Aravive
ARAV
|
886 K | - | -13.39 % | $ 1.45 M | USA |
 |
Athira Pharma
ATHA
|
970 K | - | - | $ 269 M | USA |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | Canada |
 |
Autolus Therapeutics plc
AUTL
|
7.55 M | $ 1.39 | 1.5 % | $ 355 M |  Britain |
 |
AgeX Therapeutics
AGE
|
131 K | - | -10.17 % | $ 12.2 K | USA |
 |
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | USA |
 |
Cardiff Oncology
CRDF
|
404 K | $ 1.73 | -1.43 % | $ 82.4 M | USA |
 |
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
9.45 M | - | -15.15 % | $ 60.3 M | Britain |
 |
DBV Technologies S.A.
DBVT
|
2.72 M | $ 21.75 | 0.65 % | $ 2.11 B |  France |
 |
Brickell Biotech
BBI
|
41 K | - | -5.38 % | $ 6.06 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
62.6 M | $ 14.25 | 4.13 % | $ 4.4 B | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Atreca
BCEL
|
5.46 M | - | -11.76 % | $ 5.79 M | USA |
 |
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
1.25 M | $ 6.72 | 2.05 % | $ 1.39 B | USA |